Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation
Ma'en Obeidat, Xuan Li, Stephen Burgess, Guohai Zhou, Nick Fishbane, Nadia N. Hansel, Yohan Bossé, Philippe Joubert, Ke Hao, David C. Nickle, Maarten van den Berge, Wim Timens, Michael H. Cho, Brian D. Hobbs, Kim de Jong, Marike Boezen, Rayjean J. Hung, Nicholas Rafaels, Rasika Mathias, Ingo Ruczinski, Terri H. Beaty, Kathleen C. Barnes, Peter D. Paré, Don D. Sin
Source: Eur Respir J, 50 (5) 1700657; 10.1183/13993003.00657-2017
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ma'en Obeidat, Xuan Li, Stephen Burgess, Guohai Zhou, Nick Fishbane, Nadia N. Hansel, Yohan Bossé, Philippe Joubert, Ke Hao, David C. Nickle, Maarten van den Berge, Wim Timens, Michael H. Cho, Brian D. Hobbs, Kim de Jong, Marike Boezen, Rayjean J. Hung, Nicholas Rafaels, Rasika Mathias, Ingo Ruczinski, Terri H. Beaty, Kathleen C. Barnes, Peter D. Paré, Don D. Sin. Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation. Eur Respir J, 50 (5) 1700657; 10.1183/13993003.00657-2017
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Inflammation biomarkers and risk of pulmonary hypertension: a Mendelian randomization study Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020
Plasma adiponectin and risk of asthma: observational and Mendelian randomization studies in up to 557,801 individuals Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Role of genetic factors in COPD (alpha-1-antitrypsin deficiency and other factors) Source: Annual Congress 2005 - PG13 - COPD: genetic and environmental factors, epidemiology, socio-economic impact and preventative measures Year: 2005
Late-breaking abstract: Surfactant protein D (SP-D) as a biomarker for mortality: A study in elderly Danish twins Source: Annual Congress 2011 - Lung cell biology Year: 2011
Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study Source: Eur Respir J, 59 (2) 2003979; 10.1183/13993003.03979-2020 Year: 2022
Serum 25-hydroxyvitamin D levels and risk of lung cancer and histologic types: a Mendelian randomisation analysis of the HUNT study Source: Eur Respir J, 51 (6) 1800329; 10.1183/13993003.00329-2018 Year: 2018
Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate Source: Eur Respir J 2010; 35: 768-775 Year: 2010
Age at menopause and lung function: A Mendelian randomization study Source: International Congress 2018 – Role of omics in population studies Year: 2018
Pilot: identification of rehospitalization risk factors for patients with COPD Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005
Age at menopause and lung function: a Mendelian randomisation study Source: Eur Respir J, 54 (4) 1802421; 10.1183/13993003.02421-2018 Year: 2019
Intermediate and severe α1 -antitrypsin deficiency: influence on plasma α1 -antitrypsin, FEV1 and risk of COPD. Three meta-anlyses Source: Eur Respir J 2002; 20: Suppl. 38, 513s Year: 2002
Sputum Vitamin D binding protein (VDBP) GC1S/1S genotype predicts airway obstruction: a prospective study in smokers with COPD Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020
Is COPD a risk factor for diabetes? Source: Annual Congress 2012 - COPD comorbidities II Year: 2012
Genetic determinants of lung function in COPD: A genome-wide association study Source: Annual Congress 2010 - Genetics and risk factors for asthma and COPD Year: 2010
Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population Source: Eur Respir J 2001; 18: 482-490 Year: 2001
CFTR and risk of pulmonary arterial hypertension: a case report and mendelian randomization study Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020
Systemic inflammation, genetic susceptibility and lung function Source: Eur Respir J 2008; 32: 92-97 Year: 2008
COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level Source: Annual Congress 2013 –COPD mechanisms Year: 2013
The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality Source: International Congress 2018 – Biomarkers of COPD Year: 2018
Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013